Rare Disease Impact on Understanding Common Diseases
Cat Lutz, PhD, MBA, VP at JAX Rare Disease Translational Center, discusses rare disease research’s impact on understanding common diseases.
Cat Lutz, PhD, MBA, VP at JAX Rare Disease Translational Center, discusses rare disease research’s impact on understanding common diseases.
Doris Hansen, MD, discusses the treatment of multiple myeloma using D-Rd and V-Rd in transplant-ineligible patients.
Hesham Abdullah, MD, MSc, of GSK, discusses myelofibrosis and the uses of momelotinib, also known as Ojjaara, to treat it.
The agency seeks feedback at a 13 June virtual hearing on three general topics related to advisory committees: panel composition, barriers to service for Special…
The Isabel Zendal Nursing Hospital in the Community of Madrid is now home to a specialized Day…
A big boost is coming to local ALS research in the form of $13.5 million gift to the University of Cincinnati’s Gardner Neuroscience Institute.
The administration should expand, not restrict, the program.
There was a woman with ALS, Pam Callahan, who attended a matinee last week. She is 48. She came on a rolling type of stretcher…
The funding, which is part of ACT for ALS, will support expanded access studies of drugs developed by Prilenia Therapeutics, Clene Nanomedicine and Rapa Therapeutics.